首页 > 最新文献

中国疫苗和免疫最新文献

英文 中文
[Research on the relationship between fever and H1N1 influenza vaccination in students]. [学生发热与H1N1流感疫苗接种关系研究]。
Pub Date : 2010-06-01
Li-na Tao, Hao Zhang, Sheng-hua Mao

Objective: To know the relationship between fever and H1N1 influenza vaccination among students.

Methods: Collect and analyze the data from Shanghai school absence reporting system and H1N1 influenza vaccine daily reporting system.

Results: 51 schools and 49024 students were investigated. The H1N1 influenza vaccine coverage rate was 58.5% among them. The fever rates for vaccinated and unvaccinated students were 2.41% and 7.49% respectively. It has statistic difference.

Conclusion: The H1N1 influenza vaccine was safe and the protection rate against fever was 68%.

目的:了解学生发热与接种甲型H1N1流感疫苗的关系。方法:收集和分析上海市学校缺勤报告系统和甲型H1N1流感疫苗日报告系统的数据。结果:调查51所学校,49024名学生。其中甲型H1N1流感疫苗接种率为58.5%。接种疫苗和未接种疫苗的学生发热率分别为2.41%和7.49%。它有统计差异。结论:H1N1流感疫苗安全可靠,发热保护率为68%。
{"title":"[Research on the relationship between fever and H1N1 influenza vaccination in students].","authors":"Li-na Tao,&nbsp;Hao Zhang,&nbsp;Sheng-hua Mao","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To know the relationship between fever and H1N1 influenza vaccination among students.</p><p><strong>Methods: </strong>Collect and analyze the data from Shanghai school absence reporting system and H1N1 influenza vaccine daily reporting system.</p><p><strong>Results: </strong>51 schools and 49024 students were investigated. The H1N1 influenza vaccine coverage rate was 58.5% among them. The fever rates for vaccinated and unvaccinated students were 2.41% and 7.49% respectively. It has statistic difference.</p><p><strong>Conclusion: </strong>The H1N1 influenza vaccine was safe and the protection rate against fever was 68%.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201697","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis of diphtheria antibody levels in healthy population in Beijing municipal, 2007]. 北京市健康人群白喉抗体水平分析[j]。
Pub Date : 2010-06-01
Xiao-mei Li, Dong-lei Liu, Jie Yang

Objective: To investigate the diphtheria antibody level in healthy population in Beijing.

Methods: 10 age groups (< 1, 1 to 4, 5 to 9, 10 to 14, 15 to 19, 20 to 24, 25 to 29, 30 to 34, 35 to 39, and > or =40) were sampled by the Multi-stage stratified sampling method in 9 districts in Beijing, and 2 003 sera from healthy population were collected. The diphtheria antibody was determined with ELISA method.

Results: The diphtheria antibody-positive rate was 60.26%, and the antibody concentration was 0.62 IU/ml. A trend of decreasing in the antibody concentration was observed with increasing age and years after immunization. Antibody levels were the lowest in healthy people between 25-40 years old.

Conclusion: It was predicted that a large scale of diphtheria outbreak would not occur recently in Beijing. It is recommended that for all adults diphtheria toxoids booster immunization should be conducted every 10 years for all adults.

目的:了解北京市健康人群白喉抗体水平。方法:采用多阶段分层抽样法,在北京市9个区抽取< 1岁、1 ~ 4岁、5 ~ 9岁、10 ~ 14岁、15 ~ 19岁、20 ~ 24岁、25 ~ 29岁、30 ~ 34岁、35 ~ 39岁、>或=40岁10个年龄组的健康人群血清2 003份。ELISA法检测白喉抗体。结果:白喉抗体阳性率为60.26%,抗体浓度为0.62 IU/ml。免疫后抗体浓度随年龄和年龄的增加呈下降趋势。25-40岁的健康人的抗体水平最低。结论:预测北京市近期不会发生大规模白喉疫情。建议对所有成年人每10年进行一次白喉类毒素加强免疫。
{"title":"[Analysis of diphtheria antibody levels in healthy population in Beijing municipal, 2007].","authors":"Xiao-mei Li,&nbsp;Dong-lei Liu,&nbsp;Jie Yang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the diphtheria antibody level in healthy population in Beijing.</p><p><strong>Methods: </strong>10 age groups (< 1, 1 to 4, 5 to 9, 10 to 14, 15 to 19, 20 to 24, 25 to 29, 30 to 34, 35 to 39, and > or =40) were sampled by the Multi-stage stratified sampling method in 9 districts in Beijing, and 2 003 sera from healthy population were collected. The diphtheria antibody was determined with ELISA method.</p><p><strong>Results: </strong>The diphtheria antibody-positive rate was 60.26%, and the antibody concentration was 0.62 IU/ml. A trend of decreasing in the antibody concentration was observed with increasing age and years after immunization. Antibody levels were the lowest in healthy people between 25-40 years old.</p><p><strong>Conclusion: </strong>It was predicted that a large scale of diphtheria outbreak would not occur recently in Beijing. It is recommended that for all adults diphtheria toxoids booster immunization should be conducted every 10 years for all adults.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Application of exponential smoothing method in prediction and warning of epidemic mumps]. 指数平滑法在流行性腮腺炎预测预警中的应用
Pub Date : 2010-06-01
Yun-ping Shi, Jia-qi Ma

Objective: To analyze the daily data of epidemic Mumps in a province from 2004 to 2008 and set up exponential smoothing model for the prediction.

Methods: To predict and warn the epidemic mumps in 2008 through calculating 7-day moving summation and removing the effect of weekends to the data of daily reported mumps cases during 2005-2008 and exponential summation to the data from 2005 to 2007.

Results: The performance of Holt-Winters exponential smoothing is good. The result of warning sensitivity was 76.92%, specificity was 83.33%, and timely rate was 80%.

Conclusions: It is practicable to use exponential smoothing method to warn against epidemic Mumps.

目的:分析2004 - 2008年某省流行性腮腺炎的日流行数据,建立指数平滑模型进行预测。方法:对2005-2008年流行性腮腺炎日报告病例数据进行7天移动求和,剔除周末影响,对2005- 2007年流行性腮腺炎日报告病例数据进行指数求和,对2008年流行性腮腺炎进行预测和预警。结果:Holt-Winters指数平滑法性能良好。结果提示敏感性为76.92%,特异性为83.33%,及时率为80%。结论:采用指数平滑法对流行性腮腺炎进行预警是可行的。
{"title":"[Application of exponential smoothing method in prediction and warning of epidemic mumps].","authors":"Yun-ping Shi,&nbsp;Jia-qi Ma","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To analyze the daily data of epidemic Mumps in a province from 2004 to 2008 and set up exponential smoothing model for the prediction.</p><p><strong>Methods: </strong>To predict and warn the epidemic mumps in 2008 through calculating 7-day moving summation and removing the effect of weekends to the data of daily reported mumps cases during 2005-2008 and exponential summation to the data from 2005 to 2007.</p><p><strong>Results: </strong>The performance of Holt-Winters exponential smoothing is good. The result of warning sensitivity was 76.92%, specificity was 83.33%, and timely rate was 80%.</p><p><strong>Conclusions: </strong>It is practicable to use exponential smoothing method to warn against epidemic Mumps.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201098","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis on HBV epidemical trend of people age <20 from rural areas of Zhaodong]. 赵东市农村20岁以下人群乙型肝炎病毒流行趋势分析
Pub Date : 2010-06-01
Feng Wang, Yan-cheng Liu, Kai-li Wang

Objective: By two times investigation to the HBV infection of people age <20 in rural areas in Zhaodong city, to understand the effects of HepB immunigation through analysing the changes of HBsAg, anti-HBs and anti-HBc infectious markers during 1986-2005.

Methods: Cross-sectional study was conducted and the surum samples were collected in 1986 and 2005 respectively. HBsAg, anti-HBs and anti-HBc of the sera with SPRIA were tested.

Results: HBsAg average positive rate of the people age <20 decreased from 8.5% in 1986 to 4.4% in 2005 (chi2 = 10.88, P < 0.01). The anti-HBs average positive rate increased to 43.1% in 2005 from 18.3% in 1986 (chi2 = 130.47, P < 0.01). The anti-HBc average positive rate decreased from 39.9% to 15.1% (chi2 = 122.18, P < 0.01).

Conclusion: The HBV infectious background of the rural population in Zhaodong city is high and the HBV infection rate decreased obviously after HepB inoculation since 1986, but it is still higher than the state average rate. It indicated that the HBV prevention in this district need to be enforced and improved.

目的:对1986年和2005年两次人群乙肝病毒感染情况进行调查。方法:采用横断面研究方法,分别采集样本。检测SPRIA患者血清的HBsAg、anti-HBs和anti-HBc。结论:肇东市农村人群HBV感染背景较高,自1986年以来接种乙肝疫苗后HBV感染率明显下降,但仍高于全国平均水平。提示本区HBV预防工作有待加强和改进。
{"title":"[Analysis on HBV epidemical trend of people age <20 from rural areas of Zhaodong].","authors":"Feng Wang,&nbsp;Yan-cheng Liu,&nbsp;Kai-li Wang","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>By two times investigation to the HBV infection of people age <20 in rural areas in Zhaodong city, to understand the effects of HepB immunigation through analysing the changes of HBsAg, anti-HBs and anti-HBc infectious markers during 1986-2005.</p><p><strong>Methods: </strong>Cross-sectional study was conducted and the surum samples were collected in 1986 and 2005 respectively. HBsAg, anti-HBs and anti-HBc of the sera with SPRIA were tested.</p><p><strong>Results: </strong>HBsAg average positive rate of the people age <20 decreased from 8.5% in 1986 to 4.4% in 2005 (chi2 = 10.88, P < 0.01). The anti-HBs average positive rate increased to 43.1% in 2005 from 18.3% in 1986 (chi2 = 130.47, P < 0.01). The anti-HBc average positive rate decreased from 39.9% to 15.1% (chi2 = 122.18, P < 0.01).</p><p><strong>Conclusion: </strong>The HBV infectious background of the rural population in Zhaodong city is high and the HBV infection rate decreased obviously after HepB inoculation since 1986, but it is still higher than the state average rate. It indicated that the HBV prevention in this district need to be enforced and improved.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201696","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Evaluation of the test results on hepatitis B pilot surveillance labortory in 9 provinces of China]. [中国9省乙型肝炎试点监测实验室检测结果评价]。
Pub Date : 2010-06-01
Fu-zhen Wang, Fu-qiang Cui, Xiao-hong Gong

Objective: To assess the test quality of HBsAg, anti-HBc IgM and anti-HAV IgM in the laboratories of Hepatitis B pilot surveillance provinces.

Methods: Blood serum from each of the Hepatitis B pilot surveillance provinces were collected to verify the test results. The Chemiluminescence Microparticle Immuno Assay (CMIA), ARCHITECT i2000 automatic light detector and test reagents produced by U.S.A. Abbott corporation were used in the retest. Using the Abbott reagent CMIA test results as the criteria, the domestic made ELISA reagents sensitivity, specificity, the total coincidence rate and Yoden index of HBsAg, anti-HBc IgM and anti-HAV IgM were evaluated in Hepatitis B pilot surveillance provinces.

Results: In the National Notifiable Diseases Reporting System (NNDRS) reported Hepatitis B cases, the proportion of detecting HBsAg and anti-HBc IgM was 98.53% and 39.49% respectively. Through the verification test to the reported cases in Hepatitis B pilot surveillance provinces, the original and veritication diagnosis 01 the reported eases was quite different. Among 197 acute Hepatitis B reported cases, 56 cases were agreeable with diagnosis cretirea, accounting for 28.42%. Among 1046 chronic Hepatitis B reported cases, the verification diagnosis of 602 cases was consistent with the original diagnosis, accounting for 57.55%. By using Abbott reagent and CMIA method to test again, it was found that the verification test results using domesticmade reagent and ELISA assay were low consistency compared with the test results of Abbott reagent CMIA method. The detection result of home-made reagents by ELISA compared with the Abbott reagents CMIA, the sensitivity and the total coincidence rate of HBsAg were over 95%, Kappa value was 0.439, and specificity was only 50.00%. The sensitivity, the total coincidence rate and the specificity of Anti-HBc IgM were moderate level, Kappa value was 0.516. The sensitivity of Anti-HAV IgM were 20%, and the total coincidence and specificity were higher, Kappa value was 0.033, the consistency of test was poor.

Conclusion: It's necessary to improve the detection ability of Hepatitis B etiology of indicators in order to improve the accuracy of the report of Hepatitis B cases.

目的:评价乙型肝炎监测试点省份实验室HBsAg、抗hbc IgM和抗hav IgM检测质量。方法:对各乙型肝炎监测试点省份进行血清采集,对检测结果进行验证。复测采用化学发光微粒免疫分析法(CMIA)、ARCHITECT i2000自动光检测器和美国雅培公司生产的检测试剂。以雅培试剂CMIA检测结果为标准,评价国产ELISA试剂对乙型肝炎试点监测省份HBsAg、抗hbc IgM、抗hav IgM的敏感性、特异性、总符合率及约登指数。结果:在国家传染病报告系统(NNDRS)报告的乙型肝炎病例中,检测到HBsAg和抗hbc IgM的比例分别为98.53%和39.49%。通过对乙型肝炎监测试点省份报告病例的验证检验,报告病例的原诊断与验证诊断存在较大差异。197例急性乙型肝炎病例中,符合诊断标准的有56例,占28.42%。在1046例慢性乙型肝炎报告病例中,验证诊断与原诊断一致的602例,占57.55%。通过使用Abbott试剂和CMIA法再次检测,发现国产试剂和ELISA法的验证检测结果与Abbott试剂CMIA法的检测结果一致性较低。自制试剂ELISA检测结果与雅培试剂CMIA比较,HBsAg敏感性和总符合率均在95%以上,Kappa值为0.439,特异性仅为50.00%。抗- hbc IgM的敏感性、总符合率和特异性均为中等水平,Kappa值为0.516。抗- hav IgM敏感性为20%,总符合性和特异性较高,Kappa值为0.033,检测一致性较差。结论:有必要提高乙肝病因学指标的检测能力,以提高乙肝病例报告的准确性。
{"title":"[Evaluation of the test results on hepatitis B pilot surveillance labortory in 9 provinces of China].","authors":"Fu-zhen Wang,&nbsp;Fu-qiang Cui,&nbsp;Xiao-hong Gong","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To assess the test quality of HBsAg, anti-HBc IgM and anti-HAV IgM in the laboratories of Hepatitis B pilot surveillance provinces.</p><p><strong>Methods: </strong>Blood serum from each of the Hepatitis B pilot surveillance provinces were collected to verify the test results. The Chemiluminescence Microparticle Immuno Assay (CMIA), ARCHITECT i2000 automatic light detector and test reagents produced by U.S.A. Abbott corporation were used in the retest. Using the Abbott reagent CMIA test results as the criteria, the domestic made ELISA reagents sensitivity, specificity, the total coincidence rate and Yoden index of HBsAg, anti-HBc IgM and anti-HAV IgM were evaluated in Hepatitis B pilot surveillance provinces.</p><p><strong>Results: </strong>In the National Notifiable Diseases Reporting System (NNDRS) reported Hepatitis B cases, the proportion of detecting HBsAg and anti-HBc IgM was 98.53% and 39.49% respectively. Through the verification test to the reported cases in Hepatitis B pilot surveillance provinces, the original and veritication diagnosis 01 the reported eases was quite different. Among 197 acute Hepatitis B reported cases, 56 cases were agreeable with diagnosis cretirea, accounting for 28.42%. Among 1046 chronic Hepatitis B reported cases, the verification diagnosis of 602 cases was consistent with the original diagnosis, accounting for 57.55%. By using Abbott reagent and CMIA method to test again, it was found that the verification test results using domesticmade reagent and ELISA assay were low consistency compared with the test results of Abbott reagent CMIA method. The detection result of home-made reagents by ELISA compared with the Abbott reagents CMIA, the sensitivity and the total coincidence rate of HBsAg were over 95%, Kappa value was 0.439, and specificity was only 50.00%. The sensitivity, the total coincidence rate and the specificity of Anti-HBc IgM were moderate level, Kappa value was 0.516. The sensitivity of Anti-HAV IgM were 20%, and the total coincidence and specificity were higher, Kappa value was 0.033, the consistency of test was poor.</p><p><strong>Conclusion: </strong>It's necessary to improve the detection ability of Hepatitis B etiology of indicators in order to improve the accuracy of the report of Hepatitis B cases.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)]. 甲型肝炎疫苗(HepA)接种后流行病学及血清效果分析。
Pub Date : 2010-06-01
Jian-ping Li, Zhi-xia Gao, Jian Zhou

Objective: To implement HepA vaccination and analyze epidemiological and serum effect.

Methods: The children from 1 to 14 years old were vaccinated HepA since 1992 and the HepA has been integrated into EPI to the children aged 1 year in 1996. The enzyme linked immunnosortbent assay (ELISA) was used to detect Anti-Hepatitis A Virus IgG Antibody (Anti-HAV) to analyze serum effect.

Result: HepA coverage rate from 1 to 14 years old was 80% in 1998, and it was > 90% after the year of 2001. The coverage of 1 year old children was 95%. The incidence rate of Hepatitis A reduced continuously. The incidence of whole population reduced from 25.96/100.000 in 1992 to 6.38/100.000 in 1994. In 2007, the incidence of Heptitis A decreased 98.10% compared with the incidence of the year of 1992. Epidemiological feature of Hepatitis A was changed. The positive rate of Anti-HAV was increased after vaccination of Hepatitis A Vaccine.

Conclusion: The vaccination strategy for 1 to 14 years old had obviously epidemiological and serum effect.

目的:实施HepA疫苗接种,分析流行病学和血清效果。方法:1992年开始接种1 ~ 14岁儿童HepA疫苗,1996年将HepA纳入1岁儿童免疫计划。采用酶联免疫吸附试验(ELISA)检测抗甲型肝炎病毒IgG抗体(Anti-HAV),分析血清效果。结果:1998年1 ~ 14岁儿童HepA覆盖率为80%,2001年以后达到90%以上。1岁儿童覆盖率为95%。甲肝发病率持续下降。总人口发病率由1992年的25.96/100.000下降到1994年的6.38/100.000。2007年A型肝炎的发病率比1992年下降了98.10%。改变了甲型肝炎的流行病学特征。接种甲型肝炎疫苗后,抗hav阳性率明显升高。结论:1 ~ 14岁接种策略具有明显的流行病学和血清效果。
{"title":"[Analysis on epidemiological and serum effect after vaccination of hepatitis A vaccine (HepA)].","authors":"Jian-ping Li,&nbsp;Zhi-xia Gao,&nbsp;Jian Zhou","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To implement HepA vaccination and analyze epidemiological and serum effect.</p><p><strong>Methods: </strong>The children from 1 to 14 years old were vaccinated HepA since 1992 and the HepA has been integrated into EPI to the children aged 1 year in 1996. The enzyme linked immunnosortbent assay (ELISA) was used to detect Anti-Hepatitis A Virus IgG Antibody (Anti-HAV) to analyze serum effect.</p><p><strong>Result: </strong>HepA coverage rate from 1 to 14 years old was 80% in 1998, and it was > 90% after the year of 2001. The coverage of 1 year old children was 95%. The incidence rate of Hepatitis A reduced continuously. The incidence of whole population reduced from 25.96/100.000 in 1992 to 6.38/100.000 in 1994. In 2007, the incidence of Heptitis A decreased 98.10% compared with the incidence of the year of 1992. Epidemiological feature of Hepatitis A was changed. The positive rate of Anti-HAV was increased after vaccination of Hepatitis A Vaccine.</p><p><strong>Conclusion: </strong>The vaccination strategy for 1 to 14 years old had obviously epidemiological and serum effect.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201099","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Review of the studies on primary immunodeficiency disorder and vaccine-derived poliovirus]. [原发性免疫缺陷障碍和疫苗衍生脊髓灰质炎病毒研究综述]。
Pub Date : 2010-06-01
Wei Xia, Li Li

On the last stage of Global Polio Eradication Initiative (GPEI), a number of cases with Primary Immunodeficiency (PID) disorder were detected excreting the Vaccine-derived Poliovirus (VDPV). Due to these cases can be prolonged or chronic excretion of the VDPV in the environment, all countries have to gradually focus on these cases and reconsidering the national strategies of polio vaccine in the post-eradication era themselves.

在全球根除脊髓灰质炎行动(GPEI)的最后阶段,发现了一些原发性免疫缺陷(PID)障碍病例排出疫苗衍生的脊髓灰质炎病毒(VDPV)。由于这些病例可在环境中长期或慢性地排泄VDPV,所有国家都必须逐渐关注这些病例,并重新考虑在根除后时代本身的脊髓灰质炎疫苗国家战略。
{"title":"[Review of the studies on primary immunodeficiency disorder and vaccine-derived poliovirus].","authors":"Wei Xia,&nbsp;Li Li","doi":"","DOIUrl":"","url":null,"abstract":"<p><p>On the last stage of Global Polio Eradication Initiative (GPEI), a number of cases with Primary Immunodeficiency (PID) disorder were detected excreting the Vaccine-derived Poliovirus (VDPV). Due to these cases can be prolonged or chronic excretion of the VDPV in the environment, all countries have to gradually focus on these cases and reconsidering the national strategies of polio vaccine in the post-eradication era themselves.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29200460","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Study on safety and immunogenicity of oral poliomyelitis attenuated live vaccine (human diploid cell)]. [口服脊髓灰质炎减毒活疫苗(人二倍体细胞)安全性和免疫原性研究]。
Pub Date : 2010-06-01
Shao-Hong Guo, Hong Tao, Zhi-fang Ying

Objective: To evaluate the safety and Immunogenicity of the Poliomyelitis vaccine (Human Diploid Cell) in > or =2 month-old children.

Methods: A random, blind and control trial, 1200 healthy children of 2-5 months old in Jiangsu province were administered OPV (HDC) vaccine and control vaccines. The antibody was tested by neutralization test.

Results: After 3 doses of the OPV (HDC) vaccine, the systemic reactions were mild. After 1 month of vaccination with 3 doses of the OPV (HDC) vaccine, the immune success rates of I, II, III type were 98.28%, 99.45%, and 95.71% respectively, the GMTs of I, II, III type in susceptible children were 1:1243.72, 1:234.38 and 1:273.10 respectively.

Conclusions: The OPV (HDC) vaccine was safe and immunogenicity for the children > or =2 months old.

目的:评价小儿麻痹症疫苗(人二倍体细胞疫苗)在>或=2月龄儿童中的安全性和免疫原性。方法:对江苏省1200例2 ~ 5月龄健康儿童进行随机、盲、对照试验,分别接种OPV (HDC)疫苗和对照疫苗。中和试验检测抗体。结果:接种3剂OPV (HDC)疫苗后,全身反应轻微。接种3剂OPV (HDC)疫苗1个月后,ⅰ、ⅱ、ⅲ型的免疫成功率分别为98.28%、99.45%和95.71%,易感儿童ⅰ、ⅱ、ⅲ型的GMTs分别为1:12 . 43.72、1:23 .38和1:27 . 3.10。结论:OPV (HDC)疫苗对≥2月龄儿童安全,具有免疫原性。
{"title":"[Study on safety and immunogenicity of oral poliomyelitis attenuated live vaccine (human diploid cell)].","authors":"Shao-Hong Guo,&nbsp;Hong Tao,&nbsp;Zhi-fang Ying","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To evaluate the safety and Immunogenicity of the Poliomyelitis vaccine (Human Diploid Cell) in > or =2 month-old children.</p><p><strong>Methods: </strong>A random, blind and control trial, 1200 healthy children of 2-5 months old in Jiangsu province were administered OPV (HDC) vaccine and control vaccines. The antibody was tested by neutralization test.</p><p><strong>Results: </strong>After 3 doses of the OPV (HDC) vaccine, the systemic reactions were mild. After 1 month of vaccination with 3 doses of the OPV (HDC) vaccine, the immune success rates of I, II, III type were 98.28%, 99.45%, and 95.71% respectively, the GMTs of I, II, III type in susceptible children were 1:1243.72, 1:234.38 and 1:273.10 respectively.</p><p><strong>Conclusions: </strong>The OPV (HDC) vaccine was safe and immunogenicity for the children > or =2 months old.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201692","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Optimization of method of titration rabies virus with fluorescence focus units assay]. 狂犬病病毒荧光聚焦单位法滴定方法的优化
Pub Date : 2010-06-01
Miao Chai, Ge-lin Xu, Wen Sun

Objective: A new Fluorescence Focus Units (FFU) developed for Rabies Virus titration replace current reference method (LD50) so as to reduce the cost.

Methods: The BSR cell was infected by triple serial dilution of the Rabies Virus CTN strain, then detect the fluorescent focus by FITC labeling anti-Rabies Virus monoclonal antibodies. All the samples were assayed in both FFU and LD50.

Results: Data generated indicateed that a significant correlation between the two methods (r=99).

Conclusion: This method is simple and rapid. It will be considered as a useful alternative method to the LD50.

目的:研制一种新型的狂犬病病毒荧光聚焦单元(FFU),以取代现行的参考方法(LD50),降低检测成本。方法:用狂犬病毒CTN株三倍连续稀释感染BSR细胞,用FITC标记抗狂犬病毒单克隆抗体检测荧光灶。所有样品均测定FFU和LD50。结果:生成的数据显示两种方法之间具有显著的相关性(r=99)。结论:该方法简便、快速。它将被认为是LD50的一种有用的替代方法。
{"title":"[Optimization of method of titration rabies virus with fluorescence focus units assay].","authors":"Miao Chai,&nbsp;Ge-lin Xu,&nbsp;Wen Sun","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>A new Fluorescence Focus Units (FFU) developed for Rabies Virus titration replace current reference method (LD50) so as to reduce the cost.</p><p><strong>Methods: </strong>The BSR cell was infected by triple serial dilution of the Rabies Virus CTN strain, then detect the fluorescent focus by FITC labeling anti-Rabies Virus monoclonal antibodies. All the samples were assayed in both FFU and LD50.</p><p><strong>Results: </strong>Data generated indicateed that a significant correlation between the two methods (r=99).</p><p><strong>Conclusion: </strong>This method is simple and rapid. It will be considered as a useful alternative method to the LD50.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29200455","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Investigation on varicella incidence of the children < or =14 years old in Shandong province in 2007]. [2007年山东省14岁以下儿童水痘发病率调查]。
Pub Date : 2010-06-01
Gui-fang Liu, Li-zhi Song, Lei Feng

Objective: To investigate the variceilla incidence of children age < or =14 years old in Shandong province in 2007.

Method: All children aged < or =14 and the cases of varicella were investigated from one township of rural area and one township of urban area of Jinan, Yantai, Taian, Linyi, Dezhou and Liaocheng prefecture.

Result: 48877 children aged < or =14 were investigated. The incidence of varicella was 2841.83/100,100 The incidence of varicella was different between prefectures, and it was between 719.02/100,000 to 4394155/100,000. The peak age of incidence was 5 to 9 age group children.

Conclusion: The incidence of varicella was high in Shandong province, the incidence was difierent between areas and age groups.

目的:了解2007年山东省14岁以下儿童水痘发病情况。方法:选取济南、烟台、泰安、临沂、德州、聊城5个州的农村1个乡镇和城市1个乡镇,调查所有年龄<或=14岁的儿童和水痘病例。结果:调查了48877例<或=14岁的儿童。水痘发病率为2841.83/100,100,各县水痘发病率差异较大,在719.02/ 100000 ~ 4394155/ 100000之间。发病高峰年龄为5 ~ 9岁年龄组儿童。结论:山东省水痘发病率较高,不同地区、不同年龄组水痘发病率存在差异。
{"title":"[Investigation on varicella incidence of the children < or =14 years old in Shandong province in 2007].","authors":"Gui-fang Liu,&nbsp;Li-zhi Song,&nbsp;Lei Feng","doi":"","DOIUrl":"","url":null,"abstract":"<p><strong>Objective: </strong>To investigate the variceilla incidence of children age < or =14 years old in Shandong province in 2007.</p><p><strong>Method: </strong>All children aged < or =14 and the cases of varicella were investigated from one township of rural area and one township of urban area of Jinan, Yantai, Taian, Linyi, Dezhou and Liaocheng prefecture.</p><p><strong>Result: </strong>48877 children aged < or =14 were investigated. The incidence of varicella was 2841.83/100,100 The incidence of varicella was different between prefectures, and it was between 719.02/100,000 to 4394155/100,000. The peak age of incidence was 5 to 9 age group children.</p><p><strong>Conclusion: </strong>The incidence of varicella was high in Shandong province, the incidence was difierent between areas and age groups.</p>","PeriodicalId":56402,"journal":{"name":"中国疫苗和免疫","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2010-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"29201096","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
中国疫苗和免疫
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1